Direxion Daily Gold Miners Index Bull 2X Shares (NYSE: NUGT) was sliding over 2% Tuesday as the Federal Reserve began its monthly meeting, where the Bank of America expects the central bank
Needham cut the price target for Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) from $60 to $53. Needham analyst Gil Blum maintained a Buy rating. Rocket Pharmaceuticals shares rose 24.3% to $19.00 in pre-market trading.
We performed a screening of Large-Cap ETFs, defined as having Assets Under Management (AUM) above $10 billion - to determine what funds had the largest positive and negative returns on the week, according to data from etfdb.com. Leveraged funds were excluded.
Winners
Energy Select Sector SPDR Fund (NYSEARCA: XLE)
Direxion Daily Gold Miners Index Bull 2X Shares (NYSE: NUGT) gapped up 0.73% higher on Wednesday, where the ETF ran into a group of sellers who knocked it down toward Tuesday’s high-of-day.
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he is concerned about Spirit Airlines, Inc. (NYSE: SAVE) because that "market has become very competitive.